Get Patent Opposition Report for Santen Pharmaceutical

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Santen Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3463360Aug 31, 2022Atropine-Containing Aqueous Composition2
EP3714877Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
EP3205334Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
EP2772249May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1